A pre-treatment plasma extracellular vesicle-mRNA signature associates with checkpoint inhibitor pneumonitis in lung cancer patients.
Por:
Bracht, JW, Viteri-Ramirez, S, Aguilar, A, Calabuig-Farinas, S, Garcia-Mosquera, JJ, Huang, CY, Durendez-Saez, E, Potie, N, Aldeguer, E, Gimenez-Capitan, A, Rodriguez, S, Roman, R, Aguado, C, Warren, S, Camps, C, Rosell, R, Jantus-Lewintre, E, Molina-Vila, MA and Gonzalez-Cao, M
Publicada:
1 jul 2021
Resumen:
Filiaciones:
Bracht, JW:
Univ Autonoma Barcelona, Pangaea Oncol, Barcelona, Spain
Viteri-Ramirez, S:
Dr Rosell Oncol Inst, Barcelona, Spain
Aguilar, A:
Dr Rosell Oncol Inst, Barcelona, Spain
Calabuig-Farinas, S:
Gen Univ Hosp, Valencia, Spain
Garcia-Mosquera, JJ:
Dr Rosell Oncol Inst, Barcelona, Spain
Huang, CY:
NanoString Technol, Seattle, WA USA
Durendez-Saez, E:
Gen Univ Hosp, Valencia, Spain
Potie, N:
Univ Granada, Granada, Spain
Aldeguer, E:
Pangaea Oncol, Barcelona, Spain
Gimenez-Capitan, A:
Pangaea Oncol, Barcelona, Spain
Rodriguez, S:
Pangaea Oncol, Barcelona, Spain
Roman, R:
Pangaea Oncol, Barcelona, Spain
Aguado, C:
Pangaea Oncol, Barcelona, Spain
Warren, S:
NanoString Technol, Seattle, WA USA
Camps, C:
Gen Univ Hosp, Valencia, Spain
:
Germans Trias i Pujol Hlth Sci Inst & Hosp IGTP, Badalona, Spain
Jantus-Lewintre, E:
Gen Univ Hosp, Valencia, Spain
Molina-Vila, MA:
Pangaea Oncol, Barcelona, Spain
Gonzalez-Cao, M:
Dr Rosell Oncol Inst, Barcelona, Spain
|